Published in Gene Therapy Weekly, October 12th, 2006
"The aim of the present study was to investigate bone formation to rhBMP-2-biocoated and rhBMP-2-nonbiocoated titanium implants after implantation in dogs," wrote J. Becker and colleagues, University of Dusseldorf.
"Implantation of sand-blasted and acid-etched (C), chromosulfuric acid surface-enhanced (CSA), and rhBMP-2-biocoated CSA [BMP-A: noncovalently immobilized rhBMP-2 (596 ng/cm2), BMP-B: covalently immobilized rhBMP-2 (819 ng/cm2)] implants was performed in both the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly